眼保健品市场、机会、成长动力、产业趋势分析与预测，2024-2032

2023 年，全球眼保健补充剂市场价值为26 亿美元，预计2024 年至2032 年复合年增长率为7.3%。必需营养素，和 omega-3 脂肪酸，旨在保护眼睛免受氧化压力，改善视力，并减少黄斑部病变和干眼症等与年龄相关的疾病。白内障、屈光不正、AMD 和青光眼等眼部疾病的增加推动了市场的成长。世界卫生组织在 2023 年报告称，全球有 22 亿人患有视力障碍，其中 10 亿人患有屈光不正和白内障。这增加了眼保健补充剂的采用，以支持视力健康。其他成长因素包括萤幕时间增加、产品交付技术的进步以及老年人口的成长。

整个眼保健品产业根据成分类型、适应症、配方、配销通路和地区进行分类。

细分市场包括抗氧化剂、叶黄素和玉米黄素、omega-3脂肪酸、类黄酮、α-硫辛酸、辅酶Q10、虾红素等。预计到 2032 年，叶黄素和玉米黄质市场将达到 15 亿美元。这些类胡萝卜素集中在黄斑部中，保护其免受氧化压力，并可能降低 AMD 风险。它们具有抗炎特性，可减少眼部发炎并支持眼部健康。它们的抗氧化特性支持长期眼睛健康，推动市场成长。

据指示，该市场包括白内障、眼睑结膜炎、AMD、青光眼、角膜支持、眼部疲劳等。 2023 年，AMD 细分市场的销售额为 7.802 亿美元。补充叶黄素、玉米黄质、维生素 C 和 E 以及锌有助于黄斑部健康。抗氧化剂可以中和自由基，有可能减缓 AMD 的进展。抗发炎补充剂可减少视网膜炎症，支持眼睛健康并推动 AMD 相关补充剂的需求。

预计到 2032 年，美国眼保健补充剂市场将达到 18 亿美元。在人口老化、萤幕时间增加和预防性健康关注的推动下，人们对眼睛健康的认识不断提高，刺激了对眼睛健康补充剂的需求。此外，老年性黄斑部病变 (AMD) 和白内障等疾病的日益普及进一步推动了对旨在保护视力的补充剂的需求。此外，补充剂配方的创新，包括添加抗氧化剂和 omega-3 脂肪酸，正在吸引註重健康的消费者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 眼部疾病盛行率增加
    • 萤幕活跃时间成长
    • 产品交付技术的进步
    • 老年人口不断增加
  • 产业陷阱与挑战
    • 高级补充剂相关的高成本
    • 潜在的副作用
• 成长潜力分析
• 监管环境
• 技术景观
  • 核心技术
  • 邻近技术
• 2023 年定价分析
  • 按地区
  • 按关键人物
• 未来市场趋势
• 管道分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按成分类型，2021 - 2032

• 主要趋势
• 叶黄素和玉米黄质
• 抗氧化剂
• Omega-3 脂肪酸
• 辅酶Q10
• 黄酮类化合物
• α-硫辛酸
• 虾红素
• 其他成分类型

第 6 章：市场估计与预测：按指标划分，2021 - 2032 年

• 主要趋势
• 老年黄斑部病变（AMD）
• 白内障
• 青光眼
• 眼睛疲劳
• 角膜支撑
• 眼睑结膜炎
• 其他适应症

第 7 章：市场估计与预测：按配方划分，2021 - 2032 年

• 主要趋势
• 片剂/胶囊
• 液体
• 凝胶
• 软糖
• 粉末

第 8 章：市场估计与预测：按配销通路，2021 - 2032 年

• 主要趋势
• 医院药房
• 零售药房
• 网路药房

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Alcon Inc.
• Alliance Pharma plc
• Bausch Health Companies Inc.
• Bluebonnet Nutrition
• Basic Brands Inc.
• Herbalife Ltd.
• Healthy Origins USA
• NusaPure
• Nordic Naturals
• Nestle S.A.
• Nutrivein
• Pfizer, Inc.
• Prestige Consumer Healthcare Inc.
• Vitabiotics Ltd.
• ZeaVision LLC

The Global Eye Health Supplements Market was valued at USD 2.6 billion in 2023 and is projected to grow at a 7.3% CAGR from 2024 to 2032. These supplements, containing essential nutrients like vitamins A, E, and C, zinc, zeaxanthin, lutein, and omega-3 fatty acids, aim to protect eyes from oxidative stress, improve vision, and reduce age-related conditions such as macular degeneration and dry eye syndrome. Rising eye disorders, including cataracts, refractive errors, AMD, and glaucoma, drive market growth. The WHO reported in 2023 that 2.2 billion people globally had vision impairment, with 1 billion affected by refractive errors and cataracts. This has increased the adoption of eye health supplements to support vision health. Additional growth factors include increased screen time, advancements in product delivery technologies, and a growing geriatric population.

The overall eye health supplements industry is classified based on the ingredient type, indication, formulation, distribution channel, and region.

The market segments include antioxidants, lutein and zeaxanthin, omega-3 fatty acids, flavonoids, alpha-lipoic acid, coenzyme Q10, astaxanthin, and others. The lutein and zeaxanthin segment is forecasted to reach USD 1.5 billion by 2032. Lutein and zeaxanthin filter harmful blue light, reducing digital eye strain and protecting the retina. These carotenoids are concentrated in the macula, protecting it from oxidative stress and potentially lowering AMD risk. They possess anti-inflammatory properties, reducing eye inflammation and supporting ocular health. Their antioxidant properties support long-term eye health, driving market growth.

By indication, the market includes cataracts, eyelid conjunctivitis, AMD, glaucoma, corneal support, eye fatigue, and others. The AMD segment accounted for USD 780.2 million in 2023. AMD affects the macula, crucial for sharp vision. Supplements with lutein, zeaxanthin, vitamins C and E, and zinc support macular health. Antioxidants neutralize free radicals, potentially slowing AMD progression. Anti-inflammatory supplements reduce retinal inflammation, supporting eye health and driving demand for AMD-related supplements.

The U.S. eye health supplements market is projected to reach USD 1.8 billion by 2032. The U.S. has a developed healthcare system with advanced research facilities, clinical trials, and FDA regulation, ensuring high-quality supplements. Increased awareness about eye health, driven by aging populations, high screen time, and preventive health focus, fuels demand for eye health supplements. Additionally, the growing prevalence of conditions such as age-related macular degeneration (AMD) and cataracts is further driving the need for supplements aimed at preserving vision. Furthermore, innovations in supplement formulations, including the incorporation of antioxidants and omega-3 fatty acids, are attracting health-conscious consumers.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of eye disorders
    • 3.2.1.2 Growth in active screen time
    • 3.2.1.3 Advancements in product delivery technologies
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs associated with advanced supplements
    • 3.2.2.2 Potential side effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Pricing analysis, 2023
  • 3.6.1 By region
  • 3.6.2 By key player
• 3.7 Future market trends
• 3.8 Pipeline analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Ingredient Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Lutein and zeaxanthin
• 5.3 Antioxidants
• 5.4 Omega-3 fatty acids
• 5.5 Coenzyme Q10
• 5.6 Flavonoids
• 5.7 Alpha-lipoic acid
• 5.8 Astaxanthin
• 5.9 Other ingredient types

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Age-related macular degeneration (AMD)
• 6.3 Cataract
• 6.4 Glaucoma
• 6.5 Eye fatigue
• 6.6 Corneal support
• 6.7 Eyelid conjunctivitis
• 6.8 Other indications

Chapter 7 Market Estimates and Forecast, By Formulations, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Tablet/capsule
• 7.3 Liquid
• 7.4 Gels
• 7.5 Gummies
• 7.6 Powder

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital pharmacy
• 8.3 Retail pharmacy
• 8.4 Online pharmacy

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Alcon Inc.
• 10.2 Alliance Pharma plc
• 10.3 Bausch Health Companies Inc.
• 10.4 Bluebonnet Nutrition
• 10.5 Basic Brands Inc.
• 10.6 Herbalife Ltd.
• 10.7 Healthy Origins USA
• 10.8 NusaPure
• 10.9 Nordic Naturals
• 10.10 Nestle S.A.
• 10.11 Nutrivein
• 10.12 Pfizer, Inc.
• 10.13 Prestige Consumer Healthcare Inc.
• 10.14 Vitabiotics Ltd.
• 10.15 ZeaVision LLC